Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeAgeTrial IDs
Phase IIIBiomarker/Laboratory analysis, Treatment18 to 70E1912
NCI-2014-00118, ECOG-E1912, NCT02048813

Trial Description

Summary

This randomized phase III trial studies ibrutinib and rituximab to see how well they work compared to fludarabine phosphate, cyclophosphamide, and rituximab in treating patients with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as fludarabine phosphate and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. It is not yet known whether fludarabine phosphate, cyclophosphamide, and rituximab are more effective than ibrutinib and rituximab in treating patients with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Further Study Information

PRIMARY OBJECTIVES:

I. To evaluate the ability of Ibrutinib-based induction therapy to prolong progression free survival (PFS) compared to standard fludarabine phosphate, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy for younger patients with chronic lymphocytic leukemia (CLL).

SECONDARY OBJECTIVES:

I. Evaluate overall survival (OS) of patients based on treatment arm.

II. Monitor and assess toxicity of treatment with Ibrutinib-based induction relative to standard FCR chemotherapy.

III. To compare quality of life (QOL) in CLL patients during the first 6 months of treatment among patients receiving Ibrutinib-based induction therapy relative to standard FCR chemoimmunotherapy.

IV. To compare QOL over the long-term in CLL patients receiving continuous therapy using Ibrutinib to that of CLL patients who completed FCR therapy.

V. Determine the effect of pretreatment clinical and biological characteristics (e.g. disease stage, immunoglobulin heavy chain variable region gene [IGHV] mutation status, fluorescent in situ hybridization [FISH]) on clinical outcomes (e.g. complete response, PFS) of the different arms.

VI. Determine if the minimal residual disease (MRD) status as assessed by flow cytometry at different time points during and after treatment is an effective surrogate marker for prolonged PFS and overall survival.

VII. Compare the genetic abnormalities and dynamics of intra-clonal architecture of CLL patients before and after treatment with chemoimmunotherapy (CIT) and non-CIT approaches and explore relationships with treatment resistance.

VIII. Explore the effects of FCR and Ibrutinib-based therapy on T-cell immune function.

IX. Conduct confirmatory validation genotyping of single nucleotide polymorphisms (SNPs) associated with the efficacy and toxicity of fludarabine-based therapy as in a prior Eastern Cooperative Oncology Group (ECOG) genome-wide association study (GWAS) analysis in the E2997 trial.

X. Evaluate the ability of prognostic model that incorporates clinical and biologic characters to predict a response to therapy and clinical outcome (PFS, OS).

XI. Evaluate signaling networks downstream of the B-cell receptor in patients receiving Ibrutinib-based therapy.

XII. Collect relapse samples to study mechanisms of resistance to both FCR and Ibrutinib-based therapy.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM A: Patients receive ibrutinib orally (PO) once daily (QD) on days 1-28. Beginning course 2, patients also receive rituximab intravenously (IV) over 4 hours on day 1 (days 1 and 2 of course 2 only). Treatment repeats every 28 days for 7 courses. In the absence of disease progression, patients may continue ibrutinib PO QD.

ARM B: Patients receive rituximab as seen in Arm A and fludarabine phosphate IV over 30 minutes and cyclophosphamide IV over 30 minutes on days 1-3. Treatment repeats every 28 days for 6 courses.

After completion of study treatment, patients are followed up for 10 years.

Eligibility Criteria

Inclusion Criteria:

ECOG performance status between 0-2

Life expectancy of >= 12 months

Women must not be pregnant or breast-feeding; all females of childbearing potential must have a blood test or urine study within 2 weeks prior to registration to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:

Has not undergone a hysterectomy or bilateral oophorectomy; or

Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)

Diagnosis of CLL according to the National Cancer Institute (NCI)/Internal Workshop on Chronic Lymphocytic Leukemia (IWCLL) criteria or small lymphocytic lymphoma (SLL) according to the World Health Organization (WHO) criteria; this includes previous documentation of:

Biopsy-proven small lymphocytic lymphoma OR

Diagnosis of CLL according to the NCI/IWCLL criteria as evidenced by all of the following:

  • Peripheral blood lymphocyte count of greater than 5 x10^9/L
  • Immunophenotype consistent with CLL defined as:

*** The predominant population of lymphocytes share both B-cell antigens (cluster of differentiation [CD]19, CD20 [typically dim expression], or CD23) as well as CD5 in the absence of other pan-T-cell markers (CD3, CD2, etc)

*** Clonality as evidenced by kappa or lambda light chain restriction (typically dim immunoglobulin expression)

Negative FISH analysis for t(11;14)(immunoglobulin heavy locus [IgH]/cyclin D1 [CCND1]) on peripheral blood or tissue biopsy (e.g. marrow aspirate) or negative immunohistochemical stains for cyclin D1 staining on involved tissue biopsy (e.g. marrow aspirate or lymph node biopsy)

No prior chemotherapy or monoclonal anti-body therapy for treatment of CLL or SLL

Ability to tolerate FCR based therapy

Glomerular filtration rate (GFR) > 40 mL/minute as calculated by the Cockcroft-Gault formula

No deletion of 17p13 on cytogenetic analysis by FISH

Total bilirubin =< 2.5 x upper limit of normal (ULN) unless due to Gilbert's disease; for those with a total bilirubin > 2.5 x ULN, a direct bilirubin should be performed and must be < 1.5 mg/dL for Gilbert's to be diagnosed; if value is higher due to hepatic involvement by CLL, patient is eligible

Serum glutamic oxaloacetic transaminase (SGOT) =< 2.5 x ULN; if value is higher due to hepatic involvement by CLL, patient is eligible

Able to adhere to the study visit schedule and other protocol requirements

Has met at least one of the following indications for treatment:

Evidence of progressive marrow failure as manifested by the development of worsening anemia (hemoglobin [Hg] < 11 g/dl) and/or thrombocytopenia (platelets < 100 x 10^9/L)

Symptomatic or progressive lymphadenopathy, splenomegaly, or hepatomegaly

One or more of the following disease-related symptoms:

  • Weight loss >= 10% within the previous 6 months
  • Grade 2 or 3 fatigue attributed to CLL
  • Fevers > 100.5 Fahrenheit (F) for 2 weeks without evidence of infection
  • Clinically significant night sweats without evidence of infection

Progressive lymphocytosis (not due to the effects of corticosteroids) with an increase of > 50% over a two-month period or an anticipated doubling time of less than six months

No other active primary malignancy (other than non-melanomatous skin cancer or carcinoma in situ of the cervix) requiring treatment or limiting expected survival to =< 2 years; NOTE: if there is a history of prior malignancy, they must not be receiving other specific treatment (other than hormonal therapy for their cancer)

No major surgery within the last 28 days prior to registration or minor surgery within the last 5 days

No radiation therapy =< 4 weeks prior to registration

Patients with human immunodeficiency virus (HIV) infection may be eligible provided they meet the following criteria:

CD4-positive cell count >= lower limit of institutional normal

HIV viral load < 10,000 copies HIV ribonucleic acid (RNA)/mL (if not on anti-HIV therapy) OR < 50 copies HIV RNA/mL (if on anti-HIV therapy)

No evidence of hepatitis B or C infection

No evidence of resistant strains of HIV

No history of acquired immune deficiency syndrome (AIDS)-defining condition

No active hemolytic anemia requiring immunosuppressive therapy or other pharmacologic treatment; patients who have a positive Coombs test but no evidence of hemolysis are NOT excluded from participation

No current use of corticosteroids; EXCEPTION: low doses of steroids (< 10 mg of prednisone or equivalent dose of other steroid) used for treatment of non-hematologic medical condition (e.g. chronic adrenal insufficiency) is permitted

No previous use of corticosteroids for autoimmune complications that have developed since the initial diagnosis of CLL; prior use of corticosteroids for reasons other than treatment of autoimmune complications is allowed

Patients must not have any of the following conditions:

New York Heart Association class III or IV heart disease

Recent myocardial infarction (=< 3 months)

Uncontrolled infection

Cerebral vascular accident or intracranial bleed within the last 6 months

Infection with known chronic, active hepatitis C

Positive serology for hepatitis B defined as a positive test for hepatitis B surface antigen (HBsAg); in addition, if negative for HBsAg but hepatitis B core antibody (HBcAb) positive (regardless of HBsAb status), a hepatitis B deoxyribonucleic acid (DNA) test will be performed and, if positive the subject will be ineligible

Patients are not eligible if they require chronic use of strong or moderate cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4)/5 inhibitors or inducers at the time of registration

Patients may not be on any other investigational agents

Patients may not have received warfarin or another vitamin K antagonist in the preceding 30 days

Women of childbearing potential and sexually active males must be strongly advised to use an accepted and effective method of contraception or to abstain from sexual intercourse for the duration of their participation in the study

Trial Contact Information

Trial Lead Organizations / Sponsors / Collaborators

National Cancer Institute

  • National Cancer Institute
Tait D. Shanafelt, Principal Investigator

Trial Sites

U.S.A.

Alabama
Birmingham

University of Alabama at Birmingham Cancer Center

Harry Paul Erba
Ph: 205-934-0309

Harry Paul Erba
Principal Investigator

Alaska
Anchorage

Alaska Breast Care and Surgery LLC

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Alaska Women's Cancer Care

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Anchorage Oncology Centre

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Katmai Oncology Group

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Providence Alaska Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Fairbanks

Fairbanks Memorial Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Arizona
Scottsdale

Mayo Clinic in Arizona

Tait D. Shanafelt
Ph: 507-538-7623

Tait D. Shanafelt
Principal Investigator

Arkansas
Jonesboro

Fowler Family Center for Cancer Care

Carroll Dean Scroggin
Ph: 870-972-7235

Carroll Dean Scroggin
Principal Investigator

Little Rock

University of Arkansas for Medical Sciences

Rangaswamy Govindarajan
Ph: 501-686-8274

Rangaswamy Govindarajan
Principal Investigator

California
Anaheim

Kaiser Permanente-Anaheim

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Antioch

Kaiser Permanente-Deer Valley Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Auburn

Sutter Auburn Faith Hospital

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Auburn

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Baldwin Park

Kaiser Permanente Medical Group - Baldwin Park

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Bellflower

Kaiser Foundation Hospital

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Berkeley

Alta Bates Summit Medical Center-Herrick Campus

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Burbank

Providence Saint Joseph Medical Center/Disney Family Cancer Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Burlingame

Mills - Peninsula Hospitals

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Cameron Park

Sutter Cancer Centers Radiation Oncology Services-Cameron Park

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Campbell

Southbay Oncology Hematology Partners

Steven Edward Coutre
Ph: 650-498-7061
Email: ccto-office@stanford.edu

Steven Edward Coutre
Principal Investigator

Davis

Sutter Davis Hospital

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Fontana

Kaiser Permanente Hospital

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Fremont

Kaiser Permanente, Fremont

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Fresno

Kaiser Permanente

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Greenbrae

Marin Cancer Care Inc

Peter David Eisenberg
Ph: 415-925-5000
Email: info@marinspecialtycare.com

Peter David Eisenberg
Principal Investigator

Marin General Hospital

Peter David Eisenberg
Ph: 415-925-5000
Email: info@marinspecialtycare.com

Peter David Eisenberg
Principal Investigator

Harbor City

Kaiser Permanente - Harbor City

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Irvine

Southern California Permanente Medical Group

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Los Angeles

Kaiser Permanente Los Angeles Medical Center

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Kaiser Permanente-West Los Angeles

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Modesto

Kaiser Permanente-Modesto

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Memorial Medical Center

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Mountain View

Palo Alto Medical Foundation-Camino Division

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Palo Alto Medical Foundation-Gynecologic Oncology

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Novato

Sutter Cancer Research Consortium

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Oakland

Kaiser Permanente-Oakland

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Orange

UC Irvine Health/Chao Family Comprehensive Cancer Center

Deepa Jeyakumar
Ph: 877-827-8839
Email: ucstudy@uci.edu

Deepa Jeyakumar
Principal Investigator

Palo Alto

Palo Alto Medical Foundation Health Care

Peter Paul Yu
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Peter Paul Yu
Principal Investigator

Stanford Cancer Institute

Steven Edward Coutre
Ph: 650-498-7061
Email: ccto-office@stanford.edu

Steven Edward Coutre
Principal Investigator

Panorama City

Kaiser Permanente - Panorama City

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Paradise

Feather River Cancer Center

Sam Mazj
Ph: 530-876-7995
Email: haleew@ah.org

Sam Mazj
Principal Investigator

Pismo Beach

Palchak David MD

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Redwood City

Kaiser Permanente-Redwood City

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Richmond

Kaiser Permanente-Richmond

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Riverside

Kaiser Permanente Medical Center

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Roseville

Kaiser Permanente-Roseville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Roseville

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Sutter Roseville Medical Center

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Sacramento

Kaiser Permanente - Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Kaiser Permanente-South Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter General Hospital

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

San Diego

Kaiser Permanente at San Diego

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Kaiser Permanente-San Diego Mission

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

San Francisco

California Pacific Medical Center-Pacific Campus

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Kaiser Permanente-San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Jose

Kaiser Permanente-Santa Teresa-San Jose

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Leandro

Kaiser Permanente San Leandro

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Marcos

Kaiser Permanente Health Care

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

San Rafael

Kaiser Permanente-San Rafael

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Clara

Kaiser Permanente Medical Center - Santa Clara

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Cruz

Palo Alto Medical Foundation-Santa Cruz

Peter Paul Yu
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Peter Paul Yu
Principal Investigator

Santa Rosa

Kaiser Permanente-Santa Rosa

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Pacific Medical Foundation

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

South San Francisco

Kaiser Permanente-South San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Stockton

Kaiser Permanente-Stockton

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sunnyvale

Palo Atlo Medical Foundation-Sunnyvale

Peter Paul Yu
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Peter Paul Yu
Principal Investigator

Vacaville

Kaiser Permanente Medical Center-Vacaville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Vacaville

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Vallejo

Kaiser Permanente-Vallejo

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Solano Medical Center/Cancer Center

David Alan Shiba
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

David Alan Shiba
Principal Investigator

Walnut Creek

Kaiser Permanente-Walnut Creek

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Woodland Hills

Kaiser Permanente

Jonathan A. Polikoff
Ph: 626-564-3455

Jonathan A. Polikoff
Principal Investigator

Colorado
Aurora

Rocky Mountain Cancer Centers-Aurora

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

The Medical Center of Aurora

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Boulder

Boulder Community Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Boulder

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Colorado Springs

Penrose-Saint Francis Healthcare

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Penrose

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Denver

Colorado Blood Cancer Institute

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Colorado Cancer Research Program CCOP

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Exempla Saint Joseph Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Kaiser Permanente-Franklin

Alexander Menter
Ph: 303-614-1300

Alexander Menter
Principal Investigator

Porter Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Presbyterian - Saint Lukes Medical Center - Health One

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Midtown

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Rose

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rose Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Durango

Mercy Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Southwest Oncology PC

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Englewood

Comprehensive Cancer Care and Research Institute of Colorado LLC

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Swedish Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Golden

Mountain Blue Cancer Care Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Greeley

North Colorado Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Greenwood Village

Rocky Mountain Cancer Centers-Greenwood Village

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Lafayette

Kaiser Permanente-Rock Creek

Alexander Menter
Ph: 303-614-1300

Alexander Menter
Principal Investigator

Lakewood

Rocky Mountain Cancer Centers-Lakewood

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Saint Anthony Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Littleton

Littleton Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Littleton

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Lone Tree

Kaiser Permanente-Lone Tree

Alexander Menter
Ph: 303-614-1300

Alexander Menter
Principal Investigator

Rocky Mountain Cancer Centers-Sky Ridge

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Sky Ridge Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Longmont

Longmont United Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Longmont

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Loveland

McKee Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Parker

Parker Adventist Hospital

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Parker

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Pueblo

Rocky Mountain Cancer Centers - Pueblo

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Saint Mary Corwin Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Thornton

Rocky Mountain Cancer Centers-Thornton

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Wheat Ridge

Exempla Lutheran Medical Center

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Connecticut
Derby

The Center for Cancer Care at Griffin Hospital

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Fairfield

Smilow Cancer Hospital Care Center-Fairfield

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Hartford

Saint Francis Hospital and Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Middletown

Middlesex Hospital

Susanna Hong
Ph: 860-358-2058

Susanna Hong
Principal Investigator

New Haven

Smilow Cancer Center/Yale-New Haven Hospital

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Yale University

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

North Haven

Yale-New Haven Hospital North Haven Medical Center

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Orange

Smilow Cancer Hospital-Orange Care Center

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Torrington

Charlotte Hungerford Hospital Center for Cancer Care

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Trumbull

Smilow Cancer Hospital Care Center-Trumbull

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Waterbury

Smilow Cancer Hospital at The Harold Leever Regional Cancer Center

Iris Isufi
Ph: 203-785-5702

Iris Isufi
Principal Investigator

Delaware
Lewes

Beebe Medical Center

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Newark

Christiana Care Health System-Christiana Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Christiana Gynecologic Oncology LLC

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Delaware Clinical and Laboratory Physicians PA

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Helen F Graham Cancer Center

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Medical Oncology Hematology Consultants PA

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Regional Hematology and Oncology PA

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Rehoboth Beach

Beebe Health Campus

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Seaford

Nanticoke Memorial Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Wilmington

Christiana Care Health System-Wilmington Hospital

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Florida
Lakeland

Lakeland Regional Cancer Center

Sushma Simha Nakka
Ph: 863-904-1900

Sushma Simha Nakka
Principal Investigator

Georgia
Albany

Phoebe Putney Memorial Hospital

Jose M. Tongol
Ph: 229-312-2251

Jose M. Tongol
Principal Investigator

Atlanta

Emory University/Winship Cancer Institute

Leonard Thompson Heffner
Ph: 404-778-1868

Leonard Thompson Heffner
Principal Investigator

Columbus

John B Amos Cancer Center

Andrew W. Pippas
Ph: 706-660-6404

Andrew W. Pippas
Principal Investigator

Macon

Medical Center of Central Georgia

Frederick M. Schnell
Ph: 404-501-3279

Frederick M. Schnell
Principal Investigator

Savannah

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

Grant Carlton Lewis
Ph: 912-350-8568

Grant Carlton Lewis
Principal Investigator

Hawaii
Honolulu

Kaiser Permanente Moanalua Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Idaho
Boise

Saint Alphonsus Cancer Care Center-Boise

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Illinois
Aurora

Rush - Copley Medical Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Bloomington

Illinois CancerCare-Bloomington

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Saint Joseph Medical Center

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Canton

Illinois CancerCare-Canton

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Carbondale

Memorial Hospital of Carbondale

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Carthage

Illinois CancerCare-Carthage

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Centralia

Centralia Oncology Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Chicago

Northwestern University

Shuo Ma
Ph: 312-695-1301
Email: cancer@northwestern.edu

Shuo Ma
Principal Investigator

University of Chicago Comprehensive Cancer Center

Michael J. Thirman
Ph: 773-834-7424

Michael J. Thirman
Principal Investigator

Danville

Carle on Vermilion

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Decatur

Cancer Care Center of Decatur

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Decatur Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Effingham

Carle Physician Group-Effingham

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Crossroads Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Elk Grove Village

Alexian Brothers Medical and Cancer Center

Bruce B. Bank
Ph: 847-952-7164
Email: fredianc@alexian.net

Bruce B. Bank
Principal Investigator

Eureka

Illinois CancerCare-Eureka

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Evanston

NorthShore University HealthSystem-Evanston Hospital

David L. Grinblatt
Ph: 847-570-2109

David L. Grinblatt
Principal Investigator

Galesburg

Illinois CancerCare Galesburg

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Illinois CancerCare-Galesburg Cottage Plaza Office

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Western Illinois Cancer Treatment Center

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Glenview

NorthShore University HealthSystem-Glenbrook Hospital

David L. Grinblatt
Ph: 847-570-2109

David L. Grinblatt
Principal Investigator

Highland Park

Hematology Oncology Associates of Illinois-Highland Park

Shuo Ma
Ph: 312-695-1301
Email: cancer@northwestern.edu

Shuo Ma
Principal Investigator

NorthShore University HealthSystem-Highland Park Hospital

David L. Grinblatt
Ph: 847-570-2109

David L. Grinblatt
Principal Investigator

Joliet

Joliet Oncology-Hematology Associates Limited

Kulumani M. Sivarajan
Ph: 815-730-3098
Email: maureenc@jolietoncology.com

Kulumani M. Sivarajan
Principal Investigator

Kankakee

Presence Saint Mary's Hospital

Shuo Ma
Ph: 312-695-1301
Email: cancer@northwestern.edu

Shuo Ma
Principal Investigator

Kewanee

Illinois CancerCare-Kewanee Clinic

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Libertyville

North Shore Hematology Oncology

Shuo Ma
Ph: 312-695-1301
Email: cancer@northwestern.edu

Shuo Ma
Principal Investigator

Macomb

Illinois CancerCare-Macomb

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Mattoon

Carle Physician Group-Mattoon/Charleston

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Maywood

Loyola University Medical Center

Kathleen Wren Phelan
Ph: 708-226-4357

Kathleen Wren Phelan
Principal Investigator

Mount Vernon

Good Samaritan Regional Health Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Niles

Illinois Cancer Specialists-Niles

Shuo Ma
Ph: 312-695-1301
Email: cancer@northwestern.edu

Shuo Ma
Principal Investigator

Oak Lawn

Advocate Christ Medical Center

Rami Yacoub Haddad
Ph: 800-323-8622

Rami Yacoub Haddad
Principal Investigator

Ottawa

Illinois CancerCare-Ottawa Clinic

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Radiation Oncology of Northern Illinois

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Pekin

Illinois CancerCare-Pekin

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Pekin Cancer Treatment Center

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Peoria

Illinois CancerCare-Peoria

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Methodist Medical Center of Illinois

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

OSF Saint Francis Medical Center

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

OSF Saint Francis Medical Center Radiation Oncology Service at the Central Illinois Comprehensive CC

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Peru

Illinois CancerCare-Peru

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Valley Radiation Oncology

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Princeton

Illinois CancerCare-Princeton

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Rockford

SwedishAmerican Regional Cancer Center/ACT

Harvey E. Einhorn
Ph: 779-696-9400
Email: cancercare@swedishamerican.org

Harvey E. Einhorn
Principal Investigator

Skokie

Hematology Oncology Associates of Illinois - Skokie

Shuo Ma
Ph: 312-695-1301
Email: cancer@northwestern.edu

Shuo Ma
Principal Investigator

North Shore Medical Center

David L. Grinblatt
Ph: 847-570-2109

David L. Grinblatt
Principal Investigator

Springfield

Central Illinois Hematology Oncology Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Memorial Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southern Illinois University School of Medicine

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Springfield Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Swansea

Cancer Care Specialists of Illinois-Swansea

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Urbana

Carle Cancer Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

The Carle Foundation Hospital

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Warrenville

Cadence Cancer Center in Warrenville

Robert A. Bayer
Ph: 630-208-4563
Email: kevin.tomczyk@delnor.com

Robert A. Bayer
Principal Investigator

Yorkville

Rush-Copley Healthcare Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Indiana
Michigan City

Franciscan Saint Anthony Health-Michigan City

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Woodland Cancer Care Center

Maria T. Grosse-Perdekamp
Ph: 800-446-5532

Maria T. Grosse-Perdekamp
Principal Investigator

Mishawaka

Memorial Regional Cancer Center Day Road

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Richmond

Reid Hospital and Health Care Services

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

South Bend

Memorial Hospital of South Bend

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Iowa
Ames

Mary Greeley Medical Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

McFarland Clinic PC-William R Bliss Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Boone

McFarland Clinic PC-Boone

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Clive

Medical Oncology and Hematology Associates-West Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Cancer Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Council Bluffs

Alegent Health Mercy Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Des Moines

Medical Oncology and Hematology Associates-Laurel

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Medical Center - Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Fort Dodge

McFarland Clinic PC-Trinity Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Jefferson

McFarland Clinic PC-Jefferson

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Marshalltown

McFarland Clinic PC-Marshalltown

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Mason City

Mercy Medical Center - North Iowa

Arvind Y. Vemula
Ph: 800-433-3883

Arvind Y. Vemula
Principal Investigator

Sioux City

Siouxland Regional Cancer Center

Donald B. Wender
Ph: 712-252-0088

Donald B. Wender
Principal Investigator

Waterloo

Covenant Medical Center

Mohammed T. Masri
Ph: 319-272-2070

Mohammed T. Masri
Principal Investigator

West Des Moines

Mercy Medical Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kansas
Chanute

Cancer Center of Kansas - Chanute

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Dodge City

Cancer Center of Kansas - Dodge City

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

El Dorado

Cancer Center of Kansas - El Dorado

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Fort Scott

Cancer Center of Kansas - Fort Scott

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Independence

Cancer Center of Kansas-Independence

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Kingman

Cancer Center of Kansas-Kingman

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Lawrence

Lawrence Memorial Hospital

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Liberal

Cancer Center of Kansas-Liberal

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Newton

Cancer Center of Kansas - Newton

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Parsons

Cancer Center of Kansas - Parsons

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Pratt

Cancer Center of Kansas - Pratt

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Salina

Cancer Center of Kansas - Salina

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Topeka

Stormont-Vail Regional Health Center

Mehmood Hussain Hashmi
Ph: 785-270-4963

Mehmood Hussain Hashmi
Principal Investigator

Wellington

Cancer Center of Kansas - Wellington

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Wichita

Associates In Womens Health

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas - Main Office

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas-Wichita Medical Arts Tower

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Via Christi Regional Medical Center

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Winfield

Cancer Center of Kansas - Winfield

Shaker R. Dakhil
Ph: 316-262-4467

Shaker R. Dakhil
Principal Investigator

Kentucky
Bardstown

Flaget Memorial Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Corbin

Commonwealth Cancer Center-Corbin

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Crestview Hills

Oncology Hematology Care Inc-Crestview

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Lexington

Saint Joseph Hospital East

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saint Joseph Radiation Oncology Resource Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Louisville

Jewish Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Jewish Hospital Medical Center Northeast

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saints Mary and Elizabeth Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Shepherdsville

Jewish Hospital Medical Center South

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Louisiana
Baton Rouge

Ochsner Health Center-Summa

Robert Van Buren Emmons
Ph: 888-562-4763

Robert Van Buren Emmons
Principal Investigator

Kenner

Ochsner Medical Center Kenner

Robert Van Buren Emmons
Ph: 888-562-4763

Robert Van Buren Emmons
Principal Investigator

New Orleans

Ochsner Medical Center Jefferson

Robert Van Buren Emmons
Ph: 888-562-4763

Robert Van Buren Emmons
Principal Investigator

Maine
Augusta

Harold Alfond Center for Cancer Care

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Brewer

Lafayette Family Cancer Center-EMMC

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Rockport

Penobscot Bay Medical Center

Thomas H. Openshaw
Ph: 207-973-4274

Thomas H. Openshaw
Principal Investigator

Massachusetts
Beverly

Beverly Hospital

Angus P. McIntyre
Ph: 978-283-4000ext559

Angus P. McIntyre
Principal Investigator

Boston

Eastern Cooperative Oncology Group

Tait D. Shanafelt
Ph: 507-284-2358
Email: shanafelt.tait@mayo.edu

Tait D. Shanafelt
Principal Investigator

Tufts Medical Center

Andreas Kirschmer Klein
Ph: 617-636-5000
Email: ContactUsCancerCenter@TuftsMedicalCenter.org

Andreas Kirschmer Klein
Principal Investigator

Gloucester

Addison Gilbert Hospital

Angus P. McIntyre
Ph: 978-283-4000ext559

Angus P. McIntyre
Principal Investigator

Springfield

Baystate Medical Center

Syed S. Ali
Ph: 413-794-3565
Email: tamara.wrenn@baystatehealth.org

Syed S. Ali
Principal Investigator

Worcester

University of Massachusetts Medical School

Muthalagu Ramanathan
Ph: 508-856-3216
Email: cancer.research@umassmed.edu

Muthalagu Ramanathan
Principal Investigator

Michigan
Adrian

Hickman Cancer Center

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Ann Arbor

Saint Joseph Mercy Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Clinton Township

Henry Ford Macomb Hospital

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Dearborn

Henry Ford Medical Center-Fairlane

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Oakwood Hospital and Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Detroit

Henry Ford Hospital

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Saint John Hospital and Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Wayne State University/Karmanos Cancer Institute

Jay Yang
Ph: 313-576-9363

Jay Yang
Principal Investigator

Escanaba

Green Bay Oncology - Escanaba

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Farmington

Botsford General Hospital

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Farmington Hills

Weisberg Cancer Treatment Center

Jay Yang
Ph: 313-576-9363

Jay Yang
Principal Investigator

Flint

Genesys Hurley Cancer Institute

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Hurley Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Iron Mountain

Green Bay Oncology - Iron Mountain

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Jackson

Allegiance Health

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Kalamazoo

West Michigan Cancer Center

Sunil Nagpal
Ph: 269-373-7458

Sunil Nagpal
Principal Investigator

Lansing

Sparrow Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Livonia

Saint Mary Mercy Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Monroe

Toledo Clinic Cancer Centers-Monroe

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Novi

Henry Ford Medical Center-Columbus

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Pontiac

Saint Joseph Mercy Oakland

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Port Huron

Saint Joseph Mercy Port Huron

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Roseville

Michigan Cancer Specialists

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Royal Oak

Cancer Care Associates PC

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Comprehensive Medical Center PLLC

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Hematology Oncology Consultants PC

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Oakland Colon and Rectal Association

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Oakland Medical Group

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

William Beaumont Hospital-Royal Oak

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Saginaw

Saint Mary's of Michigan

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Southfield

Providence Hospital

Robert Eric Bloom
Ph: 248-849-5337
Email: jaswinder.grewal@stjohn.org

Robert Eric Bloom
Principal Investigator

Sterling Heights

Mitchell Folbe MD PC

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Premier Hematology Oncology Care

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Trenton

Downriver Center for Oncology

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Troy

Claudia BR Herke MD PC

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Hematology Oncology Consultants PC-Troy

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Michigan Institute of Urology-Town Center

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

William Beaumont Hospital - Troy

Susanna Sergey Gaikazian
Ph: 248-551-7695

Susanna Sergey Gaikazian
Principal Investigator

Warren

Saint John Macomb-Oakland Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

West Bloomfield

Henry Ford West Bloomfield Hospital

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Minnesota
Bemidji

Sanford Clinic North-Bemidgi

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Brainerd

Essentia Health Saint Joseph's Medical Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Burnsville

Fairview Ridges Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Coon Rapids

Mercy Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Duluth

Essentia Health Cancer Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Essentia Health Saint Mary's Medical Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Miller-Dwan Hospital

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Edina

Fairview-Southdale Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Fergus Falls

Lake Region Healthcare Corporation-Cancer Care

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Fridley

Unity Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Hutchinson

Hutchinson Area Health Care

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Maplewood

Minnesota Oncology Hematology PA-Maplewood

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Saint John's Hospital - Healtheast

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Minneapolis

Abbott-Northwestern Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Health Partners Inc

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Hennepin County Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

New Ulm

New Ulm Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Robbinsdale

North Memorial Medical Health Center

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Rochester

Mayo Clinic

Tait D. Shanafelt
Ph: 507-538-7623

Tait D. Shanafelt
Principal Investigator

Saint Louis Park

Park Nicollet Clinic - Saint Louis Park

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Saint Paul

Regions Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

United Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Shakopee

Saint Francis Regional Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Stillwater

Lakeview Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Waconia

Ridgeview Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Willmar

Rice Memorial Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Woodbury

Minnesota Oncology and Hematology PA-Woodbury

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Missouri
Bolivar

Central Care Cancer Center-Carrie J Babb Cancer Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Bonne Terre

Parkland Health Center-Bonne Terre

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Branson

CoxHealth Cancer Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Cape Girardeau

Saint Francis Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southeast Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Jefferson City

Capital Region Medical Center-Goldschmidt Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Joplin

Freeman Health System

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Mercy Hospital-Joplin

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Rolla

Phelps County Regional Medical Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Saint John's Clinic-Rolla-Cancer and Hematology

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Saint Louis

Mercy Hospital Saint Louis

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Missouri Baptist Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Saint Louis Cancer and Breast Institute-South City

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Washington University School of Medicine

Nancy L. Bartlett
Ph: 800-600-3606
Email: info@siteman.wustl.edu

Nancy L. Bartlett
Principal Investigator

Sainte Genevieve

Sainte Genevieve County Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Springfield

CoxHealth South Hospital

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Mercy Hospital Springfield

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Sullivan

Missouri Baptist Sullivan Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Sunset Hills

Missouri Baptist Outpatient Center-Sunset Hills

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Montana
Billings

Billings Clinic Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Montana Cancer Consortium CCOP

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Saint Vincent Healthcare

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Bozeman

Bozeman Deaconess Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Butte

Saint James Community Hospital and Cancer Treatment Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Great Falls

Benefis Healthcare- Sletten Cancer Institute

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Helena

Saint Peter's Community Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Kalispell

Kalispell Regional Medical Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Missoula

Saint Patrick Hospital - Community Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Nebraska
Grand Island

CHI Health Saint Francis

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kearney

CHI Health Good Samaritan

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Heartland Hematology and Oncology

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Lincoln

Nebraska Cancer Research Center

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Nebraska Hematology and Oncology

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Saint Elizabeth Regional Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Southeast Nebraska Cancer Center

Gamini S. Soori
Ph: 402-991-8070
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Norfolk

Faith Regional Medical Offices West

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

North Platte

Great Plains Regional Medical Center

Gamini S. Soori
Ph: 402-991-8070
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Omaha

Alegent Health Bergan Mercy Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Immanuel Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Lakeside Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Creighton University Medical Center

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Hemotology and Oncology Consultants PC

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Missouri Valley Cancer Consortium

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Oncology Hematology West

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Oncology Hematology West PC

Gamini S. Soori
Ph: 402-991-8070
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

University of Nebraska Medical Center

Robert Gregory Bociek
Ph: 402-559-6941
Email: unmcrsa@unmc.edu

Robert Gregory Bociek
Principal Investigator

Papillion

Midlands Community Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Scottsbluff

Regional West Medical Center

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Nevada
Henderson

21st Century Oncology - Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Southeast Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas

21st Century Oncology

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

21st Century Oncology - Fort Apache

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

21st Century Oncology - Vegas Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Fort Apache

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Shadow

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer Therapy and Integrative Medicine

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Central Valley

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Northwest

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Summerlin

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-San Martin

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Nevada Cancer Research Foundation CCOP

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Central

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Southeast

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Summerlin Hospital Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

New Hampshire
Dover

Wentworth-Douglass Hospital

Taylor M. Ortiz
Ph: 603-740-2150

Taylor M. Ortiz
Principal Investigator

New Jersey
East Orange

Veterans Adminstration New Jersey Health Care System

Victor Tsu-Shih Chang
Ph: 800-475-2336
Email: patricia.goyer@med.va.gov

Victor Tsu-Shih Chang
Principal Investigator

Newark

Newark Beth Israel Medical Center

Lori Schleicher
Ph: 973-926-7230

Lori Schleicher
Principal Investigator

New Mexico
Albuquerque

University of New Mexico

Cecilia Ysabel Arana Yi
Ph: 505-272-6972

Cecilia Ysabel Arana Yi
Principal Investigator

New York
Albany

New York Oncology Hematology PC -Albany Medical Center

Charles H. Weissman
Ph: 518-489-3612
Email: gerryann.currier@usoncology.com

Charles H. Weissman
Principal Investigator

Glens Falls

Glens Falls Hospital

Mark M. Hoffman
Ph: 518-926-6700

Mark M. Hoffman
Principal Investigator

Manhasset

North Shore University Hospital

Jacqueline C. Barrientos
Ph: 516-562-3467

Jacqueline C. Barrientos
Principal Investigator

Middletown

Orange Regional Medical Center

Jeffrey M. Stewart
Ph: 845-342-7609

Jeffrey M. Stewart
Principal Investigator

New Hyde Park

Long Island Jewish Medical Center

Jacqueline C. Barrientos
Ph: 516-562-3467

Jacqueline C. Barrientos
Principal Investigator

North Shore-LIJ Health System/Center for Advanced Medicine

Jacqueline C. Barrientos
Ph: 516-562-3467

Jacqueline C. Barrientos
Principal Investigator

Rochester

University of Rochester

Jonathan Willmann Friedberg
Ph: 585-275-5830

Jonathan Willmann Friedberg
Principal Investigator

Syracuse

State University of New York Upstate Medical University

Teresa Caroline Gentile
Ph: 315-464-5476

Teresa Caroline Gentile
Principal Investigator

North Carolina
Asheville

Cancer Care of Western North Carolina

Christopher H. Chay
Ph: 828-213-4150

Christopher H. Chay
Principal Investigator

Mission Hospital-Memorial Campus

Christopher H. Chay
Ph: 828-213-4150

Christopher H. Chay
Principal Investigator

Clinton

Sampson Radiation Oncology

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Southeastern Medical Oncology Center-Clinton

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Goldsboro

Southeastern Medical Oncology Center-Goldsboro

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Wayne Memorial Hospital

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Wayne Radiation Oncology

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Hendersonville

Hendersonville Hematology and Oncology at Pardee

James Earl Radford
Ph: 828-696-4716

James Earl Radford
Principal Investigator

Margaret R Pardee Memorial Hospital

James Earl Radford
Ph: 828-696-4716

James Earl Radford
Principal Investigator

Jacksonville

Onslow Memorial Hospital

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Southeastern Medical Oncology Center-Jacksonville

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Kinston

Kinston Medical Specialists PA

Peter Robins Watson
Ph: 252-559-2200

Peter Robins Watson
Principal Investigator

Wilson

Southeastern Medical Oncology Center-Wilson

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Winston-Salem

Wake Forest University Health Sciences

Leslie Renee Ellis
Ph: 336-713-6771

Leslie Renee Ellis
Principal Investigator

North Dakota
Bismarck

Sanford Bismarck Medical Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Fargo

Essentia Health Cancer Center-South University Clinic

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Roger Maris Cancer Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Clinic North-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Medical Center-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Ohio
Beachwood

UHHS-Chagrin Highlands Medical Center

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Belpre

Strecker Cancer Center-Belpre

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Centerville

Miami Valley Hospital South

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Chardon

Geaugra Hospital

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Chillicothe

Adena Regional Medical Center

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Cincinnati

Bethesda North Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Good Samaritan Hospital - Cincinnati

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Oncology Hematology Care Inc - Anderson

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc - Kenwood

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Blue Ash

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Eden Park

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Mercy West

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

TriHealth Cancer Institute-Anderson

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

TriHealth Cancer Institute-Westside

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

University of Cincinnati

Tahir Latif
Ph: 513-558-4553
Email: uchealthnews@uc.edu

Tahir Latif
Principal Investigator

Cleveland

Case Western Reserve University

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Columbus

Columbus Oncology and Hematology Associates Inc

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Doctors Hospital

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Grant Medical Center

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Mount Carmel Health Center West

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Riverside Methodist Hospital

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

The Mark H Zangmeister Center

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Dayton

Good Samaritan Hospital - Dayton

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Miami Valley Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Samaritan North Health Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Delaware

Delaware Health Center-Grady Cancer Center

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Delaware Radiation Oncology

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Grady Memorial Hospital

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Elyria

Mercy Cancer Center-Elyria

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Fairfield

Oncology Hematology Care Inc-Healthplex

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Findlay

Blanchard Valley Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Franklin

Atrium Medical Center-Middletown Regional Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Greenville

Wayne Hospital

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Kettering

Kettering Medical Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Lancaster

Fairfield Medical Center

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Marietta

Marietta Memorial Hospital

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Maumee

Toledo Clinic Cancer Centers-Maumee

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Toledo Radiation Oncology at Northwest Ohio Onocolgy Center

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Mayfield Heights

Ireland Cancer Center Landerbrook Health Center

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Mentor

Lake University Ireland Cancer Center

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Middleburg Heights

Southwest General Health Center Ireland Cancer Center

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Mount Vernon

Knox Community Hospital

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Newark

Licking Memorial Hospital

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Newark Radiation Oncology

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Oregon

Saint Charles Hospital

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Parma

University Hospitals Parma Medical Center

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Portsmouth

Southern Ohio Medical Center

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Springfield

Springfield Regional Medical Center

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Toledo

Mercy Saint Anne Hospital

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Toledo Clinic Cancer Centers-Toledo

Rex B. Mowat
Ph: 800-444-3561

Rex B. Mowat
Principal Investigator

Troy

Upper Valley Medical Center

Howard M. Gross
Ph: 937-775-1350

Howard M. Gross
Principal Investigator

Wadsworth

University Hospitals Sharon Health Center

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

West Chester

University Pointe

Tahir Latif
Ph: 513-558-4553
Email: uchealthnews@uc.edu

Tahir Latif
Principal Investigator

Westerville

Saint Ann's Hospital

John Philip Kuebler
Ph: 614-566-3275

John Philip Kuebler
Principal Investigator

Westlake

UH-Seidman Cancer Center at Saint John Medical Center

Hillard Michael Lazarus
Ph: 800-641-2422

Hillard Michael Lazarus
Principal Investigator

Zanesville

Genesis HealthCare System

John Philip Kuebler
Ph: 614-488-2745
Email: sheree@columbusccop.org

John Philip Kuebler
Principal Investigator

Oklahoma
Lawton

Cancer Centers of Southwest Oklahoma Research

Nadim Fouad Nimeh
Ph: 877-231-4440

Nadim Fouad Nimeh
Principal Investigator

Oklahoma City

University of Oklahoma Health Sciences Center

Mohamad Cherry
Ph: 405-271-4272
Email: julie-traylor@ouhsc.edu

Mohamad Cherry
Principal Investigator

Oregon
Clackamas

Clackamas Radiation Oncology Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Providence Oncology and Hematology Care Southeast

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Newberg

Providence Newberg Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Oregon City

Providence Willamette Falls Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Portland

Kaiser Permanente

Nagendra Ranganatha Tirumali
Ph: 503-335-2400

Nagendra Ranganatha Tirumali
Principal Investigator

Providence Portland Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Providence Saint Vincent Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Pennsylvania
Allentown

Lehigh Valley Hospital-Cedar Crest

Eliot L. Friedman
Ph: 610-402-2273

Eliot L. Friedman
Principal Investigator

Beaver

UPMC-Heritage Valley Health System Beaver

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Bethlehem

Lehigh Valley Hospital - Muhlenberg

Eliot L. Friedman
Ph: 610-402-2273

Eliot L. Friedman
Principal Investigator

Bryn Mawr

Bryn Mawr Hospital

Albert S. DeNittis
Ph: 866-225-5654

Albert S. DeNittis
Principal Investigator

Chadds Ford

Christiana Care Health System-Concord Health Center

Stephen Scott Grubbs
Ph: 302-733-6227

Stephen Scott Grubbs
Principal Investigator

Clairton

UPMC Cancer Center at Jefferson Regional Medical Center

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Danville

Geisinger Medical Center

Edward J. Gorak
Ph: 570-271-5251

Edward J. Gorak
Principal Investigator

Greensburg

UPMC Cancer Centers - Arnold Palmer Pavilion

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Hazleton

Geisinger Medical Center-Cancer Center Hazleton

Edward J. Gorak
Ph: 570-271-5251

Edward J. Gorak
Principal Investigator

Hershey

Penn State Milton S Hershey Medical Center

Jeffrey J. Pu
Ph: 717-531-3779
Email: CTO@hmc.psu.edu

Jeffrey J. Pu
Principal Investigator

Johnstown

UPMC-Johnstown/John P. Murtha Regional Cancer Center

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Lancaster

Lancaster General Hospital

Shyam S. Balepur
Ph: 717-544-0511

Shyam S. Balepur
Principal Investigator

Lewisburg

Geisinger Medical Oncology at Evangelical Community Hospital

Edward J. Gorak
Ph: 570-271-5251

Edward J. Gorak
Principal Investigator

Lewistown

Lewistown Hospital

Edward J. Gorak
Ph: 570-271-5251

Edward J. Gorak
Principal Investigator

McKeesport

UPMC Cancer Center at UPMC McKeesport

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Media

Riddle Memorial Hospital

Albert S. DeNittis
Ph: 866-225-5654

Albert S. DeNittis
Principal Investigator

Moon Township

UPMC-Coraopolis/Heritage Valley Radiation Oncology

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Paoli

Paoli Memorial Hospital

Albert S. DeNittis
Ph: 866-225-5654

Albert S. DeNittis
Principal Investigator

Philadelphia

Drexel University School of Medicine

Maneesh Jain
Ph: 215-762-3950

Maneesh Jain
Principal Investigator

Thomas Jefferson University Hospital

Amy R. Mackenzie
Ph: 215-955-6084

Amy R. Mackenzie
Principal Investigator

University of Pennsylvania/Abramson Cancer Center

Anthony R. Mato
Ph: 800-474-9892

Anthony R. Mato
Principal Investigator

Pittsburgh

University of Pittsburgh Cancer Institute (UPCI)

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

UPMC-Magee Womens Hospital

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

UPMC-Passavant Hospital

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

UPMC-Presbyterian Hospital

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

UPMC-Saint Clair Hospital Cancer Center

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

UPMC-Saint Margaret

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

UPMC-Shadyside Hospital

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Pottstown

Pottstown Memorial Medical Center

Wei (Frank) Song
Ph: 610-327-7544

Wei (Frank) Song
Principal Investigator

Pottsville

Geisinger Medical Oncology-Pottsville

Edward J. Gorak
Ph: 570-271-5251

Edward J. Gorak
Principal Investigator

Scranton

Hematology and Oncology Associates of North East Pennsylvania

Amy R. Mackenzie
Ph: 215-955-6084

Amy R. Mackenzie
Principal Investigator

Seneca

UPMC Cancer Center at UPMC Northwest

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

State College

Geisinger Medical Group

Edward J. Gorak
Ph: 570-271-5251

Edward J. Gorak
Principal Investigator

Uniontown

UPMC Uniontown Hospital Radiation Oncology

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

Washington

UPMC Washington Hospital Radiation Oncology

Alison Rager Sehgal
Ph: 412-647-8073

Alison Rager Sehgal
Principal Investigator

West Reading

Reading Hospital

Terrence Paul Cescon
Ph: 610-988-9323

Terrence Paul Cescon
Principal Investigator

Wilkes-Barre

Geisinger Wyoming Valley/Henry Cancer Center

Edward J. Gorak
Ph: 570-271-5251

Edward J. Gorak
Principal Investigator

Williamsport

Susquehanna Cancer Center

Warren Lewis Robinson
Ph: 800-598-4282

Warren Lewis Robinson
Principal Investigator

Wynnewood

Lankenau Medical Center

Albert S. DeNittis
Ph: 866-225-5654

Albert S. DeNittis
Principal Investigator

South Carolina
Easley

Greenville Health System Cancer Institute-Easley

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville

Greenville Health System Cancer Institute-Andrews

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Butternut

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Eastside

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Health System Cancer Institute-Faris

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Greenville Memorial Hospital

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Saint Francis Cancer Center

Robert D. Siegel
Ph: 864-255-1713

Robert D. Siegel
Principal Investigator

Saint Francis Hospital

Robert D. Siegel
Ph: 864-255-1713

Robert D. Siegel
Principal Investigator

Greer

Greenville Health System Cancer Institute-Greer

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Seneca

Greenville Health System Cancer Institute-Seneca

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

Spartanburg

Greenville Health System Cancer Institute-Spartanburg

Jeffrey K. Giguere
Ph: 864-241-6251

Jeffrey K. Giguere
Principal Investigator

South Dakota
Rapid City

Rapid City Regional Hospital

Joshua Cole Lukenbill
Ph: 605-716-3982
Email: research@rcrh.org

Joshua Cole Lukenbill
Principal Investigator

Sioux Falls

Avera Cancer Institute

Amy K. Krie
Ph: 800-657-4377
Email: Jan.Healy@avera.org

Amy K. Krie
Principal Investigator

Sanford Cancer Center-Oncology Clinic

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford USD Medical Center - Sioux Falls

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Tennessee
Bristol

Wellmont Bristol Regional Medical Center

Asheesh Shipstone
Ph: 423-578-8538

Asheesh Shipstone
Principal Investigator

Chattanooga

Memorial Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Hixson

Pulmonary Medicine Center of Chattanooga-Hixson

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Johnson City

Wellmont Medical Associates Oncology and Hematology-Johnson City

Asheesh Shipstone
Ph: 423-578-8538

Asheesh Shipstone
Principal Investigator

Kingsport

Wellmont Holston Valley Hospital and Medical Center

Asheesh Shipstone
Ph: 423-578-8538

Asheesh Shipstone
Principal Investigator

Wellmont Medical Associates Oncology and Hematology-Kingsport

Asheesh Shipstone
Ph: 423-578-8538

Asheesh Shipstone
Principal Investigator

Nashville

Meharry Medical College

Philip Edward Lammers
Ph: 615-327-5724
Email: jmurray@mmc.edu

Philip Edward Lammers
Principal Investigator

Ooltewah

Memorial GYN Plus

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Texas
Amarillo

The Don and Sybil Harrington Cancer Center

Stewart Allen Sharp
Ph: 806-359-4673
Email: ryokubaitis@harringtoncc.org

Stewart Allen Sharp
Principal Investigator

Dallas

Parkland Memorial Hospital

Harris V. K. Naina
Ph: 214-648-7097

Harris V. K. Naina
Principal Investigator

UT Southwestern/Simmons Cancer Center-Dallas

Harris V. K. Naina
Ph: 214-648-7097

Harris V. K. Naina
Principal Investigator

Lubbock

Covenant Medical Center-Lakeside

Donald Paul Quick
Ph: 806-725-8000
Email: jaccresearch@covhs.org

Donald Paul Quick
Principal Investigator

San Antonio

University Hospital

Anand Bhasker Karnad
Ph: 210-450-3800

Anand Bhasker Karnad
Principal Investigator

University of Texas Health Science Center at San Antonio

Anand Bhasker Karnad
Ph: 210-450-3800

Anand Bhasker Karnad
Principal Investigator

Vermont
Berlin

Central Vermont Medical Center/National Life Cancer Treatment

George Fuad Atweh
Ph: 802-656-4101

George Fuad Atweh
Principal Investigator

Burlington

University of Vermont College of Medicine

George Fuad Atweh
Ph: 802-656-4101

George Fuad Atweh
Principal Investigator

Virginia
Danville

Danville Hematology Oncology

Ashantice K. Higgins
Ph: 434-793-0044

Ashantice K. Higgins
Principal Investigator

Fredericksburg

Hematology Oncology Associates of Fredericksburg Inc

Beata Holkova
Ph: 804-628-1939

Beata Holkova
Principal Investigator

Lynchburg

Lynchburg Hematology-Oncology Clinic

Beata Holkova
Ph: 804-628-1939

Beata Holkova
Principal Investigator

Martinsville

Memorial Hospital Of Martinsville

Sreedhar Katragadda
Ph: 276-666-7827

Sreedhar Katragadda
Principal Investigator

Norton

Southwest VA Regional Cancer Center

Asheesh Shipstone
Ph: 423-578-8538

Asheesh Shipstone
Principal Investigator

Richmond

Virginia Cancer Institute

Beata Holkova
Ph: 804-628-1939

Beata Holkova
Principal Investigator

Virginia Commonwealth University/Massey Cancer Center

Beata Holkova
Ph: 804-628-1939

Beata Holkova
Principal Investigator

South Hill

VCU Community Memorial Health Center

Beata Holkova
Ph: 804-628-1939

Beata Holkova
Principal Investigator

Washington
Auburn

MultiCare Auburn Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bainbridge Island

Virginia Mason Bainbridge Island Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bellevue

Overlake Hospital Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Bellingham

PeaceHealth Saint Joseph Medical Center

Michael Andre Taylor
Ph: 360-788-8223
Email: cpatz@peacehealth.org

Michael Andre Taylor
Principal Investigator

Bremerton

Harrison HealthPartners Hematology and Oncology-Bremerton

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Harrison Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Burien

Highline Medical Center-Main Campus

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Enumclaw

Saint Elizabeth Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Federal Way

Saint Francis Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Virginia Mason Federal Way Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Gig Harbor

MultiCare Gig Harbor Medical Park

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Gig Harbor

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Kennewick

Northwest Cancer Clinic

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Lakewood

Saint Clare Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Longview

Saint John Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

Lynnwood

Virginia Mason Lynnwood Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Poulsbo

Harrison HealthPartners Hematology and Oncology-Poulsbo

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Peninsula Cancer Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Puyallup

MultiCare Good Samaritan Hospital

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Puyallup

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Seattle

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Mazyar Shadman
Ph: 800-422-6237

Mazyar Shadman
Principal Investigator

Seattle Cancer Care Alliance

Mazyar Shadman
Ph: 800-422-6237

Mazyar Shadman
Principal Investigator

University of Washington Medical Center

Mazyar Shadman
Ph: 800-422-6237

Mazyar Shadman
Principal Investigator

Virginia Mason Medical Center

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma

Franciscan Research Center-Northwest Medical Plaza

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Multicare Health System

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Northwest Medical Specialties PLLC

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Jackson Hall

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Tacoma/Valley Radiation Oncology Centers-Saint Joe's

John A. Keech
Ph: 907-458-5380

John A. Keech
Principal Investigator

Vancouver

PeaceHealth Southwest Medical Center

Keith S. Lanier
Ph: 503-215-6412

Keith S. Lanier
Principal Investigator

West Virginia
Morgantown

West Virginia University Healthcare

Abraham Sebastian Kanate
Ph: 304-293-2745
Email: sfilburn@hsc.wvu.edu

Abraham Sebastian Kanate
Principal Investigator

Wisconsin
Burlington

Aurora Cancer Care-Burlington

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Chippewa Falls

Marshfield Clinic-Chippewa Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Eau Claire

Marshfield Clinic Cancer Center at Sacred Heart

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Sacred Heart Hospital

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Elkhorn

Aurora Cancer Care-Southern Lakes

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Fond Du Lac

Aurora Health Center-Fond du Lac

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Grafton

Aurora Cancer Care-Grafton

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Green Bay

Aurora BayCare Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Bellin Memorial Hospital

Patrick J. Mansky
Ph: 240-566-3584
Email: clinicaltrials@fmh.org

Patrick J. Mansky
Principal Investigator

Green Bay Oncology at Saint Vincent Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Green Bay Oncology Limited at Saint Mary's Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Saint Mary's Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Saint Vincent Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Kenosha

Aurora Cancer Care-Kenosha South

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

La Crosse

Gundersen Lutheran Medical Center

Kurt Oettel
Ph: 608-775-2385
Email: cancerctr@gundluth.org

Kurt Oettel
Principal Investigator

Ladysmith

Marshfield Clinic - Ladysmith Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Manitowoc

Holy Family Memorial Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Marinette

Vince Lombardi Cancer Clinic-Marinette

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Marshfield

Marshfield Clinic

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Saint Joseph's Hospital

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Menomonee Falls

Aurora Advanced Healthcare Inc-Menomonee Falls

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Milwaukee

Aurora Cancer Care-Milwaukee

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Cancer Care-Milwaukee South

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Saint Luke's Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Aurora Sinai Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Froedtert and the Medical College of Wisconsin

Laura Christian Michaelis
Ph: 414-805-4380

Laura Christian Michaelis
Principal Investigator

Minocqua

Marshfield Clinic-Minocqua Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Mukwonago

D N Greenwald Center

Timothy Robert Wassenaar
Ph: 262-928-7878

Timothy Robert Wassenaar
Principal Investigator

New Richmond

Cancer Center of Western Wisconsin

Joseph W. Leach
Ph: 952-993-1517
Email: MMCCOP@parknicollet.com

Joseph W. Leach
Principal Investigator

Oconomowoc

Oconomowoc Memorial Hospital-ProHealth Care Inc

Timothy Robert Wassenaar
Ph: 262-928-7878

Timothy Robert Wassenaar
Principal Investigator

Oconto Falls

Green Bay Oncology - Oconto Falls

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Oshkosh

Vince Lombardi Cancer Clinic - Oshkosh

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Racine

Aurora Cancer Care-Racine

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Rhinelander

Marshfield Clinic at James Beck Cancer Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Saint Mary's Hospital

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Rice Lake

Marshfield Clinic-Rice Lake Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Sheboygan

Saint Nicholas Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Vince Lombardi Cancer Clinic-Sheboygan

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Stevens Point

Marshfield Clinic Cancer Care at Saint Michael's Hospital

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Saint Michael's Hospital

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Sturgeon Bay

Green Bay Oncology - Sturgeon Bay

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Summit

Aurora Medical Center in Summit

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Two Rivers

Vince Lombardi Cancer Clinic

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Waukesha

Aurora Cancer Care-Waukesha

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Waukesha Memorial Hospital

Timothy Robert Wassenaar
Ph: 262-928-7878

Timothy Robert Wassenaar
Principal Investigator

Wausau

Marshfield Clinic-Wausau Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Wauwatosa

Aurora Cancer Care-Milwaukee West

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

West Allis

Aurora West Allis Medical Center

Rubina Qamar
Ph: 888-709-2080

Rubina Qamar
Principal Investigator

Weston

Diagnostic and Treatment Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Marshfield Clinic - Weston Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Saint Clare's Hospital

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Wisconsin Rapids

Marshfield Clinic - Wisconsin Rapids Center

Ali W. Bseiso
Ph: 715-389-4457

Ali W. Bseiso
Principal Investigator

Riverview Hospital

Ronnie James Kirschling
Ph: 877-405-6866

Ronnie James Kirschling
Principal Investigator

Wyoming
Cheyenne

Cheyenne Regional Medical Center-West

Keren Sturtz
Ph: 888-785-6789

Keren Sturtz
Principal Investigator

Sheridan

Welch Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT02048813

Note: Information about participating sites on pharmaceutical industry trials may be incomplete. Please visit the ClinicalTrials.gov record via the link above for more information about participating sites.